期刊文献+

肺癌相关抗原检测对非小细胞肺癌的诊断意义 被引量:4

Clinical diagnostic value of lung tumor antigen in lung cancer
暂未订购
导出
摘要 目的探讨肺癌相关抗原(lung tumor antigen LTA)在纤维支气管镜支气管肺泡灌洗液、胸水和血清中的检测结果对肺癌的临床诊断意义。方法收集72例非小细胞肺癌(non-small cell lung cancer NSCLC)伴胸腔积液患者和对照组68例肺部良性病变(benign lung disease BLD)患者的支气管肺泡灌洗液、胸水及血清样本,运用LTA检测试剂用快速乳胶凝集法分别检测,并对所得数据进行统计分析。结果肿瘤组病人支气管肺泡灌洗液、胸水和血清的LTA检测阳性率分别为58%、67%和75%,对照组三者的阳性检出率分别为22%、17%和20%,两组比较均有明显差异(P<0.05)。LTA阳性检出率以肿瘤组的血清样本最高,达75%。特异性以胸水样本最高,为82%。结论支气管肺泡灌洗液、胸水和血清LTA检测对肺癌的诊断有一定的临床参考意义。 Objective To explore the clinical diagnostic value of LTA in lung eanaer Methods Patients were divided into two groups: non-small cell lung cancer(n = 72) ; bengln lung disease (n = 68 ). The LTA levels in BLAF,pleural effusion f; luid and serum were detected by latex agglutination method. Results The NSCLC group:positive rate for LTA in BLAF ,pleural effusion and serum were 58% ,67% ,75%. While 22% ,17% ,20% in the control group. The difference between the two groups is significant( P 〈 0.05 ). Posi- tive rate of LTA in serum of the NSCLC group was the highest ,75%. The peculiarty for LTA in pleural effusion at the NSCLC group was the highest, 82%. Conclusion These results suggested that detection of LTA in BLAF,pleural effusion and serum is a valuable method for the diagnosis of lung cancer.
出处 《临床肺科杂志》 2011年第5期711-712,共2页 Journal of Clinical Pulmonary Medicine
关键词 肺癌相关抗原(LTA) 非小细胞肺癌 lung tumor antigen (LTA) , non-small cell lung cancer(NSCLC)
  • 相关文献

参考文献8

二级参考文献34

共引文献4

同被引文献37

  • 1金荣生.两种方法治疗胃肠肿瘤化疗所致呕吐的成本效果分析[J].中外医疗,2007,26(23):8-8. 被引量:3
  • 2庄翔,刘伦旭,朱文,陈利华,宋煜宏,任光国,李强,韩泳涛.肺癌患者外周血中Lunx mRNA的检测及其临床意义[J].中国胸心血管外科临床杂志,2007,14(3):184-187. 被引量:15
  • 3李秋泽,董子明,赵国强,彭培立,赵洁.黑色素瘤抗原基因MAGE-1、MAGE-3和抑癌基因p53在肺癌中表达的研究[J].现代肿瘤医学,2007,15(8):1106-1108. 被引量:8
  • 4Jemal A, Bray F, Ferlay J, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, ( published online).
  • 5Kobayashi H, Uno T, Isobe K, et al. Radiation pneumonitis following twice-daily radiotherapy with concurrent carboplatin and paclitaxel in patients with stage III non-small-cell lung cancer [J]. Jpn J Clin Oncol,2010,d0(5):464-469.
  • 6Barriger R B, Forquer J A, Brabham J G, et al. A dose- volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy [ J ]. Int J Radiationoncol, Biology, Physics, 2012,82 ( 1 ) : 457- 462.
  • 7Kim T H, Cho K H, Pyo H R, et al. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer [ J ]. Radiology, 2005,235 ( 1 ) : 208-215.
  • 8Rodrigues G, Lock M, D'Souza D, et al. Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer--a systematic review [J]. Radiother Oncol, 2004, 71(2) : 127-38.
  • 9Cedres S,Nunez I,Longo M,et a1.Serum tumor markers CEA,CYFRA21-1,and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer(NSCLC)[J].Clin Lung Cancer,2011,12(3):172-179.
  • 10唐艳,夏大文,李亚荣,万敏,菜元本.以MAGE A1-A6亚型基因mRNA为特异标记检测肺癌细胞[J].中国老年学杂志,2008,28(21):2123-2125. 被引量:4

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部